Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
As a RET gene-targeted drug, Selpercatinib can effectively treat RET-related cancers; By inhibiting key signaling pathways, it inhibits the spread and invasion of cancer cells. It ···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：202
Serpatinib is an innovative cancer treatment that targets mutations in the RET gene and reduces the growth and division of tumor cells by inhibiting specific kinases. It is especia···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：206
Selpercatinib has a significant effect on RET-mutated cancers, especially in the treatment of non-small cell lung cancer. It stops tumor development by interfering with the signali···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：183
Mitotane is a synthetic chlorinated alkyl compound, the chemical name is 1,1-dichloro-2-(O-chlorophenyl)-2-(p-chlorophenyl)ethane. It works mainly by interfering with the normal ph···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：160
Mitotane is a targeted drug that is mainly used to treat adrenocortical carcinoma and its related conditions.What is Mitotane?As a specific drug, the mechanism of action of Mitotan···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：171
Selpercatinib is a targeted therapy drug that is specifically used for cancers associated with the RET gene. It reduces the spread of cancer cells by inhibiting RET kinase. It is s···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：193
As a highly selective RET inhibitor, Selpercatinib can effectively block the RET signaling pathway. It is primarily used for the treatment of RET fusion-positive solid tumors. Pati···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：225
Pemigatinib is a targeted therapy designed for adult patients with advanced, metastatic, or unsuitable surgical resection cholangiocarcinoma who have undergone at least one round o···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：256
The core mechanism of Pemigatinib, a class of small molecule kinase blockers specifically targeting FGFR1, FGFR2, and FGFR3 receptors, lies in the effective inhibition of phosphory···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：202
Pemigatinib is the world's first targeted therapy for cholangiocarcinoma.What are the drug interactions of Pemigatinib?The metabolic process of Pemigatinib may be influenced by···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：243
Pemigatinib is a small-molecule kinase inhibitor targeting FGFR1, 2, and 3 by inhibiting phosphorylation and signaling of these receptors, thereby inhibiting tumor cell proliferati···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：171
Pemigatinibis the world's first targeted therapy for cholangiocarcinoma for the treatment of adult patients with advanced, metastatic or unresectable cholangiocarcinoma who hav···【more】
Article source：Captain MedicineRelease date：2024-08-15Recommended：197
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3172024-09-07
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：112025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：232025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：242025-27-11
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended：3062025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended：2692025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended：3492024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended：2492024-24-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
